Retraction of "Feprazone Prevents Free Fatty Acid (FFA)-Induced Endothelial Inflammation by Mitigating the Activation of the TLR4/MyD88/NF-κB Pathway"
- PMID: 39619532
- PMCID: PMC11603273
- DOI: 10.1021/acsomega.2c00977
Retraction of "Feprazone Prevents Free Fatty Acid (FFA)-Induced Endothelial Inflammation by Mitigating the Activation of the TLR4/MyD88/NF-κB Pathway"
Abstract
[This retracts the article DOI: 10.1021/acsomega.0c05826.].
© 2024 The Authors. Published by American Chemical Society.
Retraction of
-
Feprazone Prevents Free Fatty Acid (FFA)-Induced Endothelial Inflammation by Mitigating the Activation of the TLR4/MyD88/NF-κB Pathway.ACS Omega. 2021 Feb 9;6(7):4850-4856. doi: 10.1021/acsomega.0c05826. eCollection 2021 Feb 23. ACS Omega. 2021. Retraction in: ACS Omega. 2024 Nov 15;9(47):47372. doi: 10.1021/acsomega.2c00977. PMID: 33644593 Free PMC article. Retracted.
Publication types
LinkOut - more resources
Full Text Sources